NASDAQ · TMDI
Healthcare · Medical - Devices
$0.14
Up+$0.00 (+0.00%)
Updated Aug 15, 2026, 2:05 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
TMDI does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning TMDI.
TMDI research
Company profile and research snapshot.
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 25, 2022 | Oppenheimer | Perform | — |
| Apr 7, 2021 | Oppenheimer | Outperform | — |
| Oct 16, 2019 | Maxim Group | Hold | — |
| May 22, 2019 | Piper Jaffray | Overweight | — |
| Sep 17, 2018 | Northland Securities | Outperform | — |
No generated briefing is available yet.
GlobeNewswire Inc. · Mar 9, 2023
Common shares to continue to trade on the Toronto Stock Exchange and are expected to trade on the OTC Markets Common shares to continue to trade on the Toronto Stock Exchange and are expected to trade on the OTC Markets
GlobeNewswire Inc. · Feb 8, 2023
Announces Further Costing Reduction Activities and Updates to Strategic Review Process Announces Further Costing Reduction Activities and Updates to Strategic Review Process
GlobeNewswire Inc. · Jan 9, 2023
TORONTO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the unveiling of its next generation technology and participation in meetings to support the strategic review process announced on November 30, 2022 alongside the 41st Annual J.P. Morgan Healthcare Conference being held January 9-12 in San Francisco, CA. A video highlighting the company’s latest innovation in robotic-assisted surgery is available on the company’s website www.titanmedicalinc.com.
GlobeNewswire Inc. · Dec 28, 2022
TORONTO, ON, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD) (the “Company”), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that, on December 27, 2022, the Nasdaq Listing Qualifications Staff (the “Staff”) notified the Company that, based upon the Company’s non-compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Rule”) as of December 26, 2022, the Company’s securities would be delisted unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company plans to timely request a hearing, which request will stay any further action by the Staff at least pending the issuance of the Panel’s decision following the hearing and the expiration of any extension that may be granted by the Panel.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning TMDI.
No results
No recent SID articles mention TMDI.
